{"title":"新发高血压前后认知能力下降的轨迹","authors":"Qingmei Chen, Jianye Dong, Guo-Chong Chen, Haibin Li, Yueping Shen, Jianian Hua","doi":"10.1101/2024.08.03.24311456","DOIUrl":null,"url":null,"abstract":"Background: Hypertension is a known factor for cognitive impairment, especially in midlife. However, whether the cognitive function declines before and shortly after new-onset hypertension remains largely unknown. Objectives: We aimed to examine the cognitive trajectories before and after new-onset hypertension among community-dwelling midlife and older participants.\nMethods: This study included 2,964 participants from the English Longitudinal Study of Ageing who were free of hypertension at baseline. Participants who had a stroke at baseline or during follow-up were excluded. Global cognition (a summary of semantic fluency, orientation, and memory) was assessed at baseline (wave 2, 2004) and at least once from wave 3 to wave 9 (2018). New-onset hypertension was defined by self-reported doctor diagnosis, use of antihypertensive medications, and blood measurements < 140/90 mmHg. Results: Over a median follow-up of 13.6 years, 1,121 (37.8%) participants developed hypertension. The cognitive decline rate among those who later developed hypertension during the pre-hypertension period was similar to the rate among those who remained hypertension-free throughout the study. After the onset of hypertension, the rate of cognitive decline accelerated in global cognition (β, -0.015 SD/year; 95% CI, -0.026 to -0.003; p=0.011), semantic fluency (β, -0.015 SD/year; 95% CI, -0.027 to -0.003; p=0.017), and memory (β, -0.022 SD/year; 95% CI, -0.033 to -0.010; p<0.001), but not in orientation ability (β, -0.012 SD/year; 95% CI, -0.028 to 0.005; p=0.157). Participants who developed hypertension in older age did not experience a reduced impact of post-hypertension cognitive decline compared to those who developed hypertension in midlife. Conclusions: Participants experienced accelerated cognitive decline upon developing new-onset hypertension. Older participants are equally susceptible to cognitive impairment due to hypertension. Early antihypertensive initiation is crucial in both midlife and later life to protect cognitive health.","PeriodicalId":501260,"journal":{"name":"medRxiv - Nursing","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trajectories of Cognitive Decline Before and After New-onset Hypertension\",\"authors\":\"Qingmei Chen, Jianye Dong, Guo-Chong Chen, Haibin Li, Yueping Shen, Jianian Hua\",\"doi\":\"10.1101/2024.08.03.24311456\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Hypertension is a known factor for cognitive impairment, especially in midlife. However, whether the cognitive function declines before and shortly after new-onset hypertension remains largely unknown. Objectives: We aimed to examine the cognitive trajectories before and after new-onset hypertension among community-dwelling midlife and older participants.\\nMethods: This study included 2,964 participants from the English Longitudinal Study of Ageing who were free of hypertension at baseline. Participants who had a stroke at baseline or during follow-up were excluded. Global cognition (a summary of semantic fluency, orientation, and memory) was assessed at baseline (wave 2, 2004) and at least once from wave 3 to wave 9 (2018). New-onset hypertension was defined by self-reported doctor diagnosis, use of antihypertensive medications, and blood measurements < 140/90 mmHg. Results: Over a median follow-up of 13.6 years, 1,121 (37.8%) participants developed hypertension. The cognitive decline rate among those who later developed hypertension during the pre-hypertension period was similar to the rate among those who remained hypertension-free throughout the study. After the onset of hypertension, the rate of cognitive decline accelerated in global cognition (β, -0.015 SD/year; 95% CI, -0.026 to -0.003; p=0.011), semantic fluency (β, -0.015 SD/year; 95% CI, -0.027 to -0.003; p=0.017), and memory (β, -0.022 SD/year; 95% CI, -0.033 to -0.010; p<0.001), but not in orientation ability (β, -0.012 SD/year; 95% CI, -0.028 to 0.005; p=0.157). Participants who developed hypertension in older age did not experience a reduced impact of post-hypertension cognitive decline compared to those who developed hypertension in midlife. Conclusions: Participants experienced accelerated cognitive decline upon developing new-onset hypertension. Older participants are equally susceptible to cognitive impairment due to hypertension. Early antihypertensive initiation is crucial in both midlife and later life to protect cognitive health.\",\"PeriodicalId\":501260,\"journal\":{\"name\":\"medRxiv - Nursing\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Nursing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.08.03.24311456\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.03.24311456","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Trajectories of Cognitive Decline Before and After New-onset Hypertension
Background: Hypertension is a known factor for cognitive impairment, especially in midlife. However, whether the cognitive function declines before and shortly after new-onset hypertension remains largely unknown. Objectives: We aimed to examine the cognitive trajectories before and after new-onset hypertension among community-dwelling midlife and older participants.
Methods: This study included 2,964 participants from the English Longitudinal Study of Ageing who were free of hypertension at baseline. Participants who had a stroke at baseline or during follow-up were excluded. Global cognition (a summary of semantic fluency, orientation, and memory) was assessed at baseline (wave 2, 2004) and at least once from wave 3 to wave 9 (2018). New-onset hypertension was defined by self-reported doctor diagnosis, use of antihypertensive medications, and blood measurements < 140/90 mmHg. Results: Over a median follow-up of 13.6 years, 1,121 (37.8%) participants developed hypertension. The cognitive decline rate among those who later developed hypertension during the pre-hypertension period was similar to the rate among those who remained hypertension-free throughout the study. After the onset of hypertension, the rate of cognitive decline accelerated in global cognition (β, -0.015 SD/year; 95% CI, -0.026 to -0.003; p=0.011), semantic fluency (β, -0.015 SD/year; 95% CI, -0.027 to -0.003; p=0.017), and memory (β, -0.022 SD/year; 95% CI, -0.033 to -0.010; p<0.001), but not in orientation ability (β, -0.012 SD/year; 95% CI, -0.028 to 0.005; p=0.157). Participants who developed hypertension in older age did not experience a reduced impact of post-hypertension cognitive decline compared to those who developed hypertension in midlife. Conclusions: Participants experienced accelerated cognitive decline upon developing new-onset hypertension. Older participants are equally susceptible to cognitive impairment due to hypertension. Early antihypertensive initiation is crucial in both midlife and later life to protect cognitive health.